Keyphrases
Chronic Obstructive Pulmonary Disease
100%
Systemic Inflammation
100%
Local Inflammation
100%
Infliximab
100%
Inflammatory Markers
66%
Exhaled Breath Condensate
66%
Inflammation
33%
Control Subjects
33%
Myeloperoxidase
16%
Placebo
16%
Interleukin-6
16%
Tumor Necrosis Factor-α
16%
C-reactive Protein
16%
Macrophage Migration Inhibitory Factor
16%
Inflammatory Process
16%
Moderate to Severe
16%
Cachexia
16%
Inflammatory Activity
16%
Circulating Levels
16%
Severe Chronic Obstructive Pulmonary Disease
16%
Protein Binding
16%
Interleukin-12 (IL-12)
16%
Soluble Intercellular Adhesion molecule-1 (sICAM-1)
16%
RANTES
16%
Acute Phase Proteins
16%
Minor Effect
16%
Lipopolysaccharide-binding Protein
16%
Soluble TNF Receptors
16%
Clara Cell Protein 16
16%
Anti-tumor Necrosis Factor Antibody
16%
Fibrinogen-binding Protein
16%
INIS
diseases
100%
inflammation
100%
patients
63%
levels
54%
breath
36%
condensates
36%
control
27%
comparative evaluations
27%
proteins
27%
tumor necrosis factor
18%
detection
9%
antibodies
9%
receptors
9%
macrophages
9%
migration
9%
plasma
9%
c-reactive protein
9%
lipopolysaccharides
9%
fibrinogen
9%
Immunology and Microbiology
Systemic Inflammation
100%
Infliximab
100%
Breathing
80%
C-Reactive Protein
20%
Interleukin 6
20%
Blood Plasma
20%
Lipopolysaccharide Binding Protein
20%
Tumor Necrosis Factor Receptor
20%
Tumor Necrosis Factor Alpha
20%
Clara Cell
20%
Acute Phase Protein
20%
RANTES
20%
Tumor Necrosis Factor Antibody
20%
Macrophage Migration Inhibition Factor
20%
Fibrinogen
20%
Myeloperoxidase
20%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Chronic Obstructive Lung Disease
100%
Infliximab
100%
Interleukin 6
14%
C Reactive Protein
14%
Placebo
14%
Tumor Necrosis Factor
14%
Tumor Necrosis Factor Receptor
14%
Lipopolysaccharide Binding Protein
14%
Cachexia
14%
Myeloperoxidase
14%
Fibrinogen
14%
Protein C
14%
Acute Phase Protein
14%
Clara Cell Protein
14%
RANTES
14%
Tumor Necrosis Factor Antibody
14%
Macrophage Migration Inhibition Factor
14%